List of Excipients in API clindamycin phosphate and benzoyl peroxide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing clindamycin phosphate and benzoyl peroxide
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Bausch Health US LLC | ONEXTON | clindamycin phosphate and benzoyl peroxide | 0187-3050 | CARBOMER HOMOPOLYMER TYPE C | |
| Bausch Health US LLC | ONEXTON | clindamycin phosphate and benzoyl peroxide | 0187-3050 | POTASSIUM HYDROXIDE | |
| Bausch Health US LLC | ONEXTON | clindamycin phosphate and benzoyl peroxide | 0187-3050 | PROPYLENE GLYCOL | |
| Bausch Health US LLC | ONEXTON | clindamycin phosphate and benzoyl peroxide | 0187-3050 | WATER | |
| Bausch Health US LLC | BENZACLIN | clindamycin phosphate and benzoyl peroxide | 0187-5190 | DOCUSATE SODIUM | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing clindamycin phosphate and benzoyl peroxide
Detailed excipient profiles for clindamycin phosphate and benzoyl peroxide
Excipient focus: CARBOMER HOMOPOLYMER TYPE B
clindamycin phosphate and benzoyl peroxide drug variants containing CARBOMER HOMOPOLYMER TYPE B
| Company | Ingredient | NDC |
|---|---|---|
| Medimetriks Pharmaceuticals | clindamycin phosphate and benzoyl peroxide | 43538-176 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate and benzoyl peroxide drug variants not containing CARBOMER HOMOPOLYMER TYPE B
Excipient focus: CARBOMER HOMOPOLYMER TYPE C
clindamycin phosphate and benzoyl peroxide drug variants containing CARBOMER HOMOPOLYMER TYPE C
clindamycin phosphate and benzoyl peroxide drug variants not containing CARBOMER HOMOPOLYMER TYPE C
Excipient focus: DIMETHICONE
clindamycin phosphate and benzoyl peroxide drug variants containing DIMETHICONE
clindamycin phosphate and benzoyl peroxide drug variants not containing DIMETHICONE
Excipient focus: DISODIUM LAURYL SULFOSUCCINATE
clindamycin phosphate and benzoyl peroxide drug variants containing DISODIUM LAURYL SULFOSUCCINATE
clindamycin phosphate and benzoyl peroxide drug variants not containing DISODIUM LAURYL SULFOSUCCINATE
Excipient focus: DOCUSATE SODIUM
clindamycin phosphate and benzoyl peroxide drug variants containing DOCUSATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | clindamycin phosphate and benzoyl peroxide | 0187-5190 |
| Oceanside Pharmaceuticals | clindamycin phosphate and benzoyl peroxide | 68682-190 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate and benzoyl peroxide drug variants not containing DOCUSATE SODIUM
Excipient focus: EDETATE DISODIUM
clindamycin phosphate and benzoyl peroxide drug variants containing EDETATE DISODIUM
clindamycin phosphate and benzoyl peroxide drug variants not containing EDETATE DISODIUM
Excipient focus: EDETATE SODIUM
clindamycin phosphate and benzoyl peroxide drug variants containing EDETATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | clindamycin phosphate and benzoyl peroxide | 70710-1445 |
| Zydus Lifesciences Limited | clindamycin phosphate and benzoyl peroxide | 70771-1450 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate and benzoyl peroxide drug variants not containing EDETATE SODIUM
Excipient focus: GLYCERIN
clindamycin phosphate and benzoyl peroxide drug variants containing GLYCERIN
clindamycin phosphate and benzoyl peroxide drug variants not containing GLYCERIN
Excipient focus: HYDROCHLORIC ACID
clindamycin phosphate and benzoyl peroxide drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Medimetriks Pharmaceuticals | clindamycin phosphate and benzoyl peroxide | 43538-176 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate and benzoyl peroxide drug variants not containing HYDROCHLORIC ACID
Excipient focus: METHYLPARABEN
clindamycin phosphate and benzoyl peroxide drug variants containing METHYLPARABEN
clindamycin phosphate and benzoyl peroxide drug variants not containing METHYLPARABEN
Excipient focus: POLOXAMER 124
clindamycin phosphate and benzoyl peroxide drug variants containing POLOXAMER 124
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | clindamycin phosphate and benzoyl peroxide | 51672-1367 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate and benzoyl peroxide drug variants not containing POLOXAMER 124
Excipient focus: POLOXAMER 182
clindamycin phosphate and benzoyl peroxide drug variants containing POLOXAMER 182
clindamycin phosphate and benzoyl peroxide drug variants not containing POLOXAMER 182
Excipient focus: POTASSIUM HYDROXIDE
clindamycin phosphate and benzoyl peroxide drug variants containing POTASSIUM HYDROXIDE
clindamycin phosphate and benzoyl peroxide drug variants not containing POTASSIUM HYDROXIDE
Excipient focus: PROPYLENE GLYCOL
clindamycin phosphate and benzoyl peroxide drug variants containing PROPYLENE GLYCOL
clindamycin phosphate and benzoyl peroxide drug variants not containing PROPYLENE GLYCOL
Excipient focus: PROPYLPARABEN
clindamycin phosphate and benzoyl peroxide drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Medimetriks Pharmaceuticals | clindamycin phosphate and benzoyl peroxide | 43538-176 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate and benzoyl peroxide drug variants not containing PROPYLPARABEN
Excipient focus: SILICON DIOXIDE
clindamycin phosphate and benzoyl peroxide drug variants containing SILICON DIOXIDE
clindamycin phosphate and benzoyl peroxide drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM HYDROXIDE
clindamycin phosphate and benzoyl peroxide drug variants containing SODIUM HYDROXIDE
clindamycin phosphate and benzoyl peroxide drug variants not containing SODIUM HYDROXIDE
Excipient focus: WATER
clindamycin phosphate and benzoyl peroxide drug variants containing WATER
clindamycin phosphate and benzoyl peroxide drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
